| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 65,711 | 77,596 | ||
| Prepaid expenses and other current assets | 2,462 | 2,843 | ||
| Total current assets | 68,173 | 80,439 | ||
| Property and equipment, net | 5,088 | 5,490 | ||
| Restricted cash and cash equivalents | 898 | 895 | ||
| Operating lease right of use asset | 5,422 | 5,620 | ||
| Other assets | 46 | 122 | ||
| Total assets | 79,627 | 92,566 | ||
| Accounts payable | 1,078 | 2,774 | ||
| Accrued expenses and other current liabilities | 9,021 | 8,543 | ||
| Operating lease liability, current | 1,504 | 1,454 | ||
| Note payable, current | 6,000 | 2,400 | ||
| Total current liabilities | 17,603 | 15,171 | ||
| Operating lease liability, net of current portion | 8,140 | 8,587 | ||
| Note payable, net of discount, issuance costs, and current portion | 21,656 | 24,705 | ||
| Derivative liability | 2,614 | 2,639 | ||
| Total liabilities | 50,013 | 51,102 | ||
| Common stock, 0.0001 par value, 200,000,000 shares authorized as of september30, 2025 and december31, 2024 47,273,685 and 44,827,159 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively | 5 | 5 | ||
| Additional paid-in capital | 496,638 | 492,118 | ||
| Accumulated deficit | -467,029 | -450,659 | ||
| Total stockholders equity | 29,614 | 41,464 | ||
| Total liabilities and stockholders equity | 79,627 | 92,566 | ||
Werewolf Therapeutics, Inc. (HOWL)
Werewolf Therapeutics, Inc. (HOWL)